Case number 3:24-cv-10458
ASTRAZENECA PHARMACEUTICALS LP et al v. ZYDUS PHARMACEUTICALS (USA) INC. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 27, 2025 | 25 | ANSWER to Counterclaim by ASTRAZENECA AB, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, KUDOS PHARMACEUTICALS LIMITED, MSD INTERNATIONAL BUSINESS GMBH, THE UNIVERSITY OF SHEFFIELD.(CHEVALIER, CHARLES) (Entered: 02/27/2025) (13) |
| Feb 27, 2025 | 26 | STIPULATION AND ORDER of Dismissal of Certain Counts. Signed by Judge Robert Kirsch on 2/27/2025. (mlh) (Entered: 02/27/2025) (5) |
| Feb 27, 2025 | 27 | CONSENT ORDER AND JUDGMENT of Non-Infringement regarding U.S. Patent No. 8,475,842. Signed by Judge Robert Kirsch on 2/27/2025. (mlh) (Entered: 02/27/2025) (5) |
| Feb 26, 2025 | 24 | Letter from Charles H. Chevalier, Esq. to the Honorable Robert Kirsch, U.S.D.J.. (Attachments: # 1 Stipulation and [Proposed] Order of Dismissal of Certain Counts, # 2 Consent Decree and Judgment of Non-Infringement Regarding U.S. Patent No. 8,475,842)(CHEVALIER, CHARLES) (Entered: 02/26/2025) (0) |
| Feb 21, 2025 | 23 | STIPULATION AND ORDER extending the time for Plaintiff's to respond to Defendant's counterclaims until 2/27/2025. Signed by Magistrate Judge Tonianne J. Bongiovanni on 2/20/2025. (jal, ) (Entered: 02/21/2025) (4) |
| Feb 20, 2025 | 22 | Letter from Charles H. Chevalier to The Honorable Tonianne J. Bongiovanni, U.S.M.J. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 02/20/2025) (0) |
| Feb 18, 2025 | 21 | STIPULATION AND ORDER extending time to answer counterclaims until 2/20/2025. Signed by Magistrate Judge Tonianne J. Bongiovanni on 2/18/2025. (jal, ) (Entered: 02/18/2025) (4) |
| Feb 12, 2025 | 20 | Letter from Charles H. Chevalier to the Honorable Tonianne J. Bongiovanni, U.S.M.J.. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 02/12/2025) (0) |
| Feb 7, 2025 | 19 | STIPULATION AND ORDER that the time by which Plaintiffs are required to answer or otherwise respond to Defendants' counterclaims in the No. 3:24-10458 action and the No. 3:24-10629 action is extended through and including 2/13/2025. Signed by Magistrate Judge Tonianne J. Bongiovanni on 2/7/2025. (kht) (Entered: 02/07/2025) (4) |
| Feb 6, 2025 | 18 | Letter from Charles H. Chevalier to the Honorable Tonianne J. Bongiovanni, U.S.M.J.. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 02/06/2025) (0) |
| Jan 24, 2025 | 17 | STIPULATION AND ORDER Extending time to answer counterclaims through and including 2/6/2025. Signed by Magistrate Judge Tonianne J. Bongiovanni on 1/23/2025. (amv) (Entered: 01/24/2025) (4) |
| Jan 23, 2025 | 16 | Letter from Charles H. Chevalier to the Honorable Tonianne J. Bongiovanni, U.S.M.J.. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 01/23/2025) (0) |
| Dec 20, 2024 | 14 | STIPULATION AND ORDER that Civil Action Nos. 3:24-10458, 3:24-10624, 3:24-10627, 3:24-10628, and 3:24-10629 are hereby consolidated for all pretrial purposes and that all papers be maintained in Civil Action No. 3:23-796. Signed by Magistrate Judge Tonianne J. Bongiovanni on 12/20/2024. (kht) (Entered: 12/20/2024) (8) |
| Dec 20, 2024 | 15 | Application and Proposed Order for Clerk's Order to extend time to answer as to Defendants' Counterclaims.. (CHEVALIER, CHARLES) (Entered: 12/20/2024) (4) |
| Dec 20, 2024 | N/A | Clerk`s Text Order - The 15 Application for Clerk's Order to Ext Answer/Proposed Order submitted by ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH, KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA AB, THE UNIVERSITY OF SHEFFIELD, ASTRAZENECA PHARMACEUTICALS LP has been GRANTED. The answer due date has been set for 1/23/2025. (amv) Modified on 12/20/2024 (amv). (Entered: 12/20/2024) (0) |
| Dec 19, 2024 | 12 | ANSWER to Complaint Affirmative Defenses, COUNTERCLAIM Counterclaims to Plaintiffs' Complaint against ASTRAZENECA AB, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, KUDOS PHARMACEUTICALS LIMITED, MSD INTERNATIONAL BUSINESS GMBH, THE UNIVERSITY OF SHEFFIELD by ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS LIFESCIENCES LIMITED.(MCCORMICK, THEODORA) (Entered: 12/19/2024) (30) |
| Dec 19, 2024 | 13 | Corporate Disclosure Statement by ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS LIFESCIENCES LIMITED. (MCCORMICK, THEODORA) (Entered: 12/19/2024) (2) |
| Nov 15, 2024 | 10 | WAIVER OF SERVICE Returned Executed by MSD INTERNATIONAL BUSINESS GMBH, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, ASTRAZENECA PHARMACEUTICALS LP, KUDOS PHARMACEUTICALS LIMITED, THE UNIVERSITY OF SHEFFIELD. ZYDUS PHARMACEUTICALS (USA) INC. waiver sent on 11/14/2024, answer due 1/13/2025. (CHEVALIER, CHARLES) (Entered: 11/15/2024) (1) |
| Nov 15, 2024 | 11 | WAIVER OF SERVICE Returned Executed by MSD INTERNATIONAL BUSINESS GMBH, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, ASTRAZENECA PHARMACEUTICALS LP, KUDOS PHARMACEUTICALS LIMITED, THE UNIVERSITY OF SHEFFIELD. ZYDUS LIFESCIENCES LIMITED waiver sent on 11/14/2024, answer due 1/13/2025. (CHEVALIER, CHARLES) (Entered: 11/15/2024) (1) |
| Nov 13, 2024 | N/A | Judge Robert Kirsch and Magistrate Judge Tonianne J. Bongiovanni added. (jjc, ) (Entered: 11/13/2024) (0) |
| Nov 13, 2024 | 8 | SUMMONS ISSUED as to ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jjc, ) (Entered: 11/13/2024) (2) |
| Nov 13, 2024 | 9 | AO120 Patent Form filed. (jjc, ) (Entered: 11/13/2024) (1) |
| Nov 12, 2024 | 1 | COMPLAINT against ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15802467) , Related Case Selected, filed by MSD INTERNATIONAL BUSINESS GMBH, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, ASTRAZENECA PHARMACEUTICALS LP, KUDOS PHARMACEUTICALS LIMITED, THE UNIVERSITY OF SHEFFIELD. (Attachments: # 1 Exhibit A ('562 patent), # 2 Exhibit B ('842 patent), # 3 Exhibit C ('396 patent), # 4 Exhibit D ('001 patent), # 5 Exhibit E ('695 patent), # 6 Certification Pursuant to Local Civil Rule 11.2, # 7 Civil Cover Sheet)(CHEVALIER, CHARLES) (Entered: 11/12/2024) (0) |
| Nov 12, 2024 | 2 | Corporate Disclosure Statement by ASTRAZENECA PHARMACEUTICALS LP identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 11/12/2024) (2) |
| Nov 12, 2024 | 3 | Corporate Disclosure Statement by ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 11/12/2024) (2) |
| Nov 12, 2024 | 4 | Corporate Disclosure Statement by ASTRAZENECA AB identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 11/12/2024) (2) |
| Nov 12, 2024 | 5 | Corporate Disclosure Statement by KUDOS PHARMACEUTICALS LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 11/12/2024) (2) |
| Nov 12, 2024 | 6 | Corporate Disclosure Statement by THE UNIVERSITY OF SHEFFIELD. (CHEVALIER, CHARLES) (Entered: 11/12/2024) (2) |
| Nov 12, 2024 | 7 | Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck & Co. as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 11/12/2024) (2) |
